Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Change in Account Payables (2020 - 2025)

Rapid Micro Biosystems' Change in Account Payables history spans 6 years, with the latest figure at $251000.0 for Q3 2025.

  • For Q3 2025, Change in Account Payables rose 67.33% year-over-year to $251000.0; the TTM value through Sep 2025 reached $1.3 million, up 233.48%, while the annual FY2024 figure was $562000.0, 116.27% up from the prior year.
  • Change in Account Payables for Q3 2025 was $251000.0 at Rapid Micro Biosystems, down from $700000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.9 million in Q3 2023 and bottomed at -$4.1 million in Q1 2023.
  • The 5-year median for Change in Account Payables is $100000.0 (2025), against an average of -$46421.1.
  • The largest annual shift saw Change in Account Payables tumbled 1037.5% in 2022 before it surged 1219.48% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at $1.7 million in 2021, then grew by 3.96% to $1.8 million in 2022, then tumbled by 173.79% to -$1.3 million in 2023, then skyrocketed by 115.79% to $205000.0 in 2024, then rose by 22.44% to $251000.0 in 2025.
  • Per Business Quant, the three most recent readings for RPID's Change in Account Payables are $251000.0 (Q3 2025), $700000.0 (Q2 2025), and $100000.0 (Q1 2025).